| 48.86 -0.88 (-1.77%) | 10-22 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 65.81 |
1-year : | 72.28 |
| Resists | First : | 56.35 |
Second : | 61.88 |
| Pivot price | 50.8  |
|||
| Supports | First : | 47.38 |
Second : | 39.42 |
| MAs | MA(5) : | 49.97 |
MA(20) : | 50.47 |
| MA(100) : | 49.7 |
MA(250) : | 0 | |
| MACD | MACD : | -1.3 |
Signal : | -1.2 |
| %K %D | K(14,3) : | 33.6 |
D(3) : | 35.4 |
| RSI | RSI(14): 41.8 |
|||
| 52-week | High : | 62.18 | Low : | 33.42 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ HNGE ] has closed above bottom band by 11.1%. Bollinger Bands are 0% narrower than normal.
| If tomorrow: | Open lower | Open higher |
| High: | 49.58 - 49.89 | 49.89 - 50.11 |
| Low: | 46.67 - 47.05 | 47.05 - 47.32 |
| Close: | 48.35 - 48.92 | 48.92 - 49.32 |
Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.
Thu, 23 Oct 2025
FNY Investment Advisers LLC Acquires Shares of 6,000 Hinge Health Inc. $HNGE - MarketBeat
Tue, 21 Oct 2025
Hinge Health unveils new AI-powered care tools - Business Wire
Sun, 19 Oct 2025
Hinge Health Inc. (NYSE:HNGE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Mon, 06 Oct 2025
Hinge Health: Experiencing Both Growth And Significant Risks, Hold Ahead Of Q3 Earnings - Seeking Alpha
Fri, 03 Oct 2025
Assessing Hinge Health (HNGE) Valuation After Recent Share Price Gains and New Partnerships - Sahm
Wed, 01 Oct 2025
Hinge Health to announce third quarter 2025 financial results on November 4, 2025 - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 27 (M) |
| Shares Float | 22 (M) |
| Held by Insiders | 8 (%) |
| Held by Institutions | 132.8 (%) |
| Shares Short | 2,040 (K) |
| Shares Short P.Month | 1,260 (K) |
| EPS | -5.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.22 |
| Profit Margin | -88.8 % |
| Operating Margin | -417.5 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 54.9 % |
| Gross Profit (p.s.) | 13.77 |
| Sales Per Share | 17.66 |
| EBITDA (p.s.) | -19.87 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 92 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -8.95 |
| PEG Ratio | 0 |
| Price to Book value | 22 |
| Price to Sales | 2.76 |
| Price to Cash Flow | 14.47 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|